Joseph Lyssikatos
Gründer bei ENLIVEN THERAPEUTICS, INC.
Vermögen: 19 Mio $ am 30.04.2024
Profil
Joseph P.
Lyssikatos is the founder.
He founded Enliven Therapeutics, Inc. in 2019 and currently holds the title of Director & Chief Scientific Officer.
Dr. Lyssikatos is also the founder of Enliven Therapeutics, Inc. Dr. Lyssikatos's former job positions include Executive Director at AbbVie, Inc. and Senior Director at Array BioPharma, Inc. Dr. Lyssikatos's education history includes an undergraduate degree from The College of William & Mary and a doctorate degree from the University of California, Berkeley.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 29.05.2024 | 1 117 035 ( 2,39% ) | 19 Mio $ | 30.04.2024 |
Aktive Positionen von Joseph Lyssikatos
| Unternehmen | Position | Beginn |
|---|---|---|
| ENLIVEN THERAPEUTICS, INC. | Gründer | 01.06.2019 |
Enliven Therapeutics, Inc. /US/
 Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology EnLiven Therapeutics, Inc. engages in the discovery and development of small molecule treatments for cancer. The company was founded by Samuel S. Kintz and is headquartered in San Francisco, CA. | Gründer | - |
Ehemalige bekannte Positionen von Joseph Lyssikatos
| Unternehmen | Position | Ende |
|---|---|---|
| ARRAY TECHNOLOGIES, INC. | Direktor/Vorstandsmitglied | - |
| ABBVIE INC. | Direktor/Vorstandsmitglied | - |
Ausbildung von Joseph Lyssikatos
| The College of William & Mary | Undergraduate Degree |
| University of California, Berkeley | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ENLIVEN THERAPEUTICS, INC. | Health Technology |
| ABBVIE INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Enliven Therapeutics, Inc. /US/
Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology EnLiven Therapeutics, Inc. engages in the discovery and development of small molecule treatments for cancer. The company was founded by Samuel S. Kintz and is headquartered in San Francisco, CA. | Health Technology |
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO. | Health Technology |
